Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-11

Clinical Trial Update: Uterine Leiomyoma Treatment With Radiofrequency Ablation (ULTRA) Registry

View source ↗

Summary

The ULTRA registry evaluating radiofrequency ablation for uterine fibroids is ongoing but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of California, San Francisco | Conditions: Uterine Fibroids | Status: ACTIVE_NOT_RECRUITING